New research indicates that people who discontinue new slimming jabs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who halt conventional lifestyle programs.
Research printed in a major health publication demonstrates that while overweight individuals can lose substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Individuals using these medications need to be aware of the potential of quick weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
This pace of regain means a reversion to starting mass within about a year and a half.
Comparing Approaches
The research, which looked at dozens of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with older methods.
Scientists emphasize that people who shed pounds through diet and exercise typically have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Doctors propose the way of the drugs explains the accelerated rebound.
The injections copy a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone levels several times higher than the body's typical production might result in the system to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating a significant risk."
A Lifelong Disease?
Medical guidelines recommend the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.
A number of clinicians say that, given the likelihood of relapse, the therapy might need to be ongoing.
This view is supported by drug manufacturers, who say that the findings "underscore the long-term nature of obesity," akin to managing diseases like hypertension.
User Accounts
Users who have come off the medication report a intense resurgence of cravings.
"It felt as if a trigger flipping and you're instantly starving," said an individual.
The struggle is worsened if individuals have not established sustainable lifestyle or habit modifications during treatment.
Significant Use
Recent estimates indicate that millions of people in the UK have tried these injections in the past year, with demand continuing to grow.
- Use is more common among women compared to males.
- The middle-aged age group shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while these medications are potent tools for weight loss, they are not a magic solution and long-term success likely depends on combined lifestyle management.
